Factor Xa (FXa) inhibitors are direct oral anticoagulants (DOACs) and safe and effective alternatives to warfarin in preventing stroke in patients with atrial fibrillation and treating venous thrombosis [1]. This evidence concerns the gene F10 and Venous thrombosis.